Predictive value of soluble ST-2 for changes of cardiac function and structure in breast cancer patients receiving chemotherapy

The current study was to evaluate soluble ST-2 level and left ventricular ejection fraction (LVEF) in patients with breast cancer receiving doxorubicin or trastuzumab treatment for 6 months and determine whether soluble ST-2 level can be used to predictive left ventricular function impairment. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Guoding, Zhai, Jianfeng, Huang, Xinting, Zheng, Dongdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160077/
https://www.ncbi.nlm.nih.gov/pubmed/30235730
http://dx.doi.org/10.1097/MD.0000000000012447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160077/
https://www.ncbi.nlm.nih.gov/pubmed/30235730
http://dx.doi.org/10.1097/MD.0000000000012447

Ejemplares similares